Laboratorios Farmaceuticos Rovi, S.A Stock (BME:ROVI)


Today's Range
€58.70 - €60.80
52-Week Range
€29.93 - €68.80
Market Cap

About Laboratorios Farmaceuticos Rovi, S.A (BME:ROVI)

(BME:ROVI) Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company also distributes other products that are licensed from other laboratories. Its principal products include Hibor, a low-molecular-weight heparin to prevent thromboembolic disease; Enoxaparin biosimilar, a low-molecular-weight heparin; Neparvis for the treatment of symptomatic chronic heart failure with reduced ejection in adult patients; Absorcol, Vytorin, and Orvatez to diet in patients with hypercholesterolemia; Hirobriz Breezhaler and Ulunar Breezhaler that are long-acting bronchodilators for the maintenance treatment of chronic obstructive pulmonary diseases; Volutsa for the treatment of moderate to severe storage systems symptoms and voiding symptoms associated with benign prostatic hyperplasia in men who are not responding adequately to monotherapy treatment; and Medikinet and Medicebrán that are prescription medicines for treatment of attention deficit hyperactivity disorder in children and adolescents. The company also markets various hospital products for imaging diagnosis, such as Iomeron and Iopamiro for computed tomography and intervention; Multihance and Prohance for magnetic resonance imaging; Sonovue for ultrasounds; and EmpowerCTA+, EmpowerMR, and CT Exprès that are contrast injection systems and compatible disposable material. In addition, it provides non-prescription pharmaceutical products; and contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, hard capsules, and sachets. The company serves wholesalers, doctors, nursing staff, pharmacists, and patients. It has a collaboration with Moderna, Inc. for manufacturing COVID-19 vaccine candidate. Laboratorios Farmaceuticos Rovi, S.A. was founded in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Invers
Show more

ROVI Stock Price

Statistics Highlights (BME:ROVI)

Shares Outstanding 55.40M Beta 0.62
Public Float 19.21M P/E Ratio 40.16
% Short of Float - Dividend (Yield) 0.38 (0.01%)
Held by Insiders 65.23% Ex-Dividend Date Jul 5, 2021
Held by Institutions 19.04% IPO Date Dec 5, 2007

ROVI Financial Summary

Dec 20 Dec 19 Dec 18
Revenue €419.96M €381.31M €303.20M
EBITDA €92.98M €60.74M €29.44M
Net Income €61.06M €39.27M €17.89M
Total Assets €574.44M €511.21M €402.70M
Total Cash €53.16M €67.43M €95.51M
Total Debt
Jun 21 Mar 21 Dec 20
Revenue €159.50M €130.55M €117.82M
EBITDA €40.14M €34.90M €23.55M
Net Income €27.18M €23.84M €14.23M
Total Assets €644.25M €591.38M €574.44M
Total Cash €126.75M €72.62M €53.16M
Total Debt

ROVI Stock Price History

Laboratorios Farmaceuticos Rovi, S.A Annual Stock Price History

Year Open Close Change
2022 €73.00 €60.00 -17.81%
2021 €37.80 €73.00 93.12%
2020 €24.90 €37.80 51.81%

Laboratorios Farmaceuticos Rovi, S.A Daily Stock Price History

Date Open High Low Close Change Volume
Jan 21, 2022 €64.20 €64.50 €63.00 €63.00 -2.48% 103.40K

(BME:ROVI) Stock Price FAQs

What is today's stock price of Laboratorios Farmaceuticos Rovi, S.A (BME:ROVI)?

  • The current stock price of Laboratorios Farmaceuticos Rovi, S.A (BME:ROVI) is €60.00.
  • Today ROVI stock price opened at €60.10 after previous close of €59.50.
  • During the day, Laboratorios Farmaceuticos Rovi, S.A stock quote has varied from a low of €58.70 to a high of €60.80.

What is Laboratorios Farmaceuticos Rovi, S.A's 52-week change?

  • ROVI 52-week high stock quote is €68.80, which is 14.70% above the current share price.
  • The Laboratorios Farmaceuticos Rovi, S.A (BME:ROVI) 52-week low stock price is €29.93, which is 50.10% below the current share price.
  • Laboratorios Farmaceuticos Rovi, S.A share price volatility (52-week beta) is 0.62.

Laboratorios Farmaceuticos Rovi, S.A (BME:ROVI) FAQ

How Much is Laboratorios farmaceuticos rovi, s.a Worth?

Laboratorios farmaceuticos rovi, s.a's worth today based on market capitalisation is €3.32B

How much dividend does Laboratorios farmaceuticos rovi, s.a Pay?

The current annualized dividend payout for ROVI stock is €0.38, the dividend yield is 0.64% and the payout ratio is 30.26%.
View More Details on Laboratorios farmaceuticos rovi, s.a's "Dividend" Section

What is Laboratorios farmaceuticos rovi, s.a’s Price to Earning (PE) ratio?

Laboratorios farmaceuticos rovi, s.a has a Price to Earning (P/E) ratio of 40.16. ROVI stock also has a Price to Sales (P/S) ratio of 6.41.

What is the Laboratorios farmaceuticos rovi, s.a's ticker?

Laboratorios farmaceuticos rovi, s.a trades on the Madrid stock market in Spain under the ticker symbol "ROVI". Laboratorios farmaceuticos rovi, s.a’s stock symbol can also be displayed as "BME:ROVI".

When did ROVI go public?

Laboratorios farmaceuticos rovi, s.a completed its initial public offering (IPO) on December 05 ,2007.

Who are the owners of Laboratorios farmaceuticos rovi, s.a?

Laboratorios farmaceuticos rovi, s.a (BME:ROVI) is owned by 19.04% institutional shareholders and by 65.23% insiders. The rest is owned by the public.
Explore More Details on Laboratorios farmaceuticos rovi, s.a's “Ownership” Section

Who are the key executives of Laboratorios farmaceuticos rovi, s.a (ROVI)?

Laboratorios farmaceuticos rovi, s.a's key executive team includes the following managers:

  • Mr. Juan Lopez-Belmonte Encina, CEO & Director (NA)
  • Mr. Ivan Lopez-Belmonte Encina, First Deputy Chairman & Head of Corp. Devel. (NA)
  • Mr. Javier Lopez-Belmonte Encina, Second Deputy Chairman & CFO (NA)
  • Ms. Mercedes Benítez del Castillo Sánchez, Legal Department Mang. (NA)
  • Mr. Fernando Martínez Morales, Director of Sales (NA)
  • Ms. Rosario Perucha Pérez, Marketing Mang. (NA)
  • Mr. Francisco Javier Angulo García, HR Mang. (NA)
  • Mr. Gabriel Núñez Fernández, Sec. (NA)
  • Mr. Ignacio Zarzalejos Toledano, Deputy Sec. (NA)

What is Laboratorios farmaceuticos rovi, s.a’s Sector & Industry Classification?

Laboratorios farmaceuticos rovi, s.a (BME:ROVI) is classified under the "Healthcare" sector and under the "Biotechnology" industry.

How many employees work for Laboratorios farmaceuticos rovi, s.a?

Currently the number of employees working for Laboratorios farmaceuticos rovi, s.a is 1,499.

Where are Laboratorios farmaceuticos rovi, s.a's Headquarters?

Laboratorios farmaceuticos rovi, s.a (BME:ROVI) is headquartered in Spain.

What are Laboratorios farmaceuticos rovi, s.a's Address and Phone Number?

Laboratorios farmaceuticos rovi, s.a’s mailing address is Calle José Isbert, 2, Madrid, Spain, 28223.
The company’s phone number is 34 91 021 30 00.

What is the official website for Laboratorios farmaceuticos rovi, s.a?

Laboratorios farmaceuticos rovi, s.a’s official website is